ANTIMICROBIAL INNOVATION ALLIANCE
Development of antimicrobial resistance policy to assist life sciences industry.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2025
|
FORBES-TATE | — reported |
|
3rd Quarter - Report 3rd Quarter 2025
|
FORBES-TATE | — reported |
|
2nd Quarter - Report 2nd Quarter 2025
|
FORBES-TATE | — reported |
|
1st Quarter - Report 1st Quarter 2025
|
FORBES-TATE | — reported |
|
4th Quarter - Report 4th Quarter 2024
|
FORBES-TATE | — reported |
|
3rd Quarter - Report 3rd Quarter 2024
|
FORBES-TATE | — reported |
|
2nd Quarter - Report 2nd Quarter 2024
|
FORBES-TATE | — reported |
|
1st Quarter - Report 1st Quarter 2024
|
FORBES-TATE | — reported |
|
4th Quarter - Report 4th Quarter 2023
|
FORBES-TATE | — reported |
|
3rd Quarter - Report 3rd Quarter 2023
|
FORBES-TATE | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE MCMANUS GROUP | 27 | $1,170,000 |
| FORBES-TATE | 19 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 41 |
| Medicare/Medicaid | MMM | 13 |
| Budget/Appropriations | BUD | 5 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.